膽囊癌的規范化手術治療_CHINESE JOURNAL OF BASES AND CLINICS IN GENERAL SURGERY

Authors：

李斌 ,  姜小清

海軍軍醫大學膽道腫瘤專病中心東方肝膽外科醫院膽道一科（上海 ?200438）;

Corresponding?author：

姜小清, Email: jxq1225@sina.com

Keywords：

DOI：

10.7507/1007-9424.201902073

Video：

Export PDF Favorites Scan Get Citation

Abstract Full text Figures/Tables Video References Cited by

Citation： 李斌, 姜小清. 膽囊癌的規范化手術治療. CHINESE JOURNAL OF BASES AND CLINICS IN GENERAL SURGERY, 2019, 26(3): 265-269. doi: 10.7507/1007-9424.201902073 Copy

1.	Edge SB, Byrd DR, Compton CC, et al. AJCC Cancer Staging Manual. 7th ed. New York: Springer, 2009: 211-217.
2.	American Cancer Society. Cancer Facts and Figures 2013. Atlanta, GA: American Cancer Society, 2013.
3.	Miquel JF, Covarrubias C, Villaroel L, et al. Genetic epidemiology of cholesterol cholelithiasis among Chilean Hispanics, Ame-rindians, and Maoris. Gastroenterology, 1998, 115(4): 937-946.
4.	Sampliner RE, Bennett PH, Comess LJ, et al. Gallbladder disease in pima indians. Demonstration of high prevalence and early onset by cholecystography. N Engl J Med, 1970, 283(25): 1358-1364.
5.	Zatonski WA, Lowenfels AB, Boyle P, et al. Epidemiologic aspects of gallbladder cancer: a case-control study of the SEARCH Program of the International Agency for Research on Cancer. J Natl Cancer Inst, 1997, 89(15): 1132-1138.
6.	Everhart JE, Yeh F, Lee ET, et al. Prevalence of gallbladder disease in American Indian populations: findings from the Strong Heart Study. Hepatology, 2002, 35(6): 1507-1512.
7.	Yamauchi S, Koga A, Matsumoto S, et al. Anomalous junction of pancreaticobiliary duct without congenital choledochal cyst: a possible risk factor for gallbladder cancer. Am J Gastroenterol, 1987, 82(1): 20-24.
8.	Chijiiwa K, Kimura H, Tanaka M. Malignant potential of the gallbladder in patients with anomalous pancreaticobiliary ductal junction. The difference in risk between patients with and without choledochal cyst. Int Surg, 1995, 80(1): 61-64.
9.	Bai Y, Liu ZS, Xiong JP, et al. Nomogram to predict overall survival after gallbladder cancer resection in China. World J Gastroenterol, 2018, 24(45): 5167-5178.
10.	Kanthan R, Senger JL, Ahmed S, et al. Gallbladder Cancer in the 21^st Century. J Oncol, 2015, 2015: 967472.
11.	Goetze TO. Gallbladder carcinoma: Prognostic factors and therapeutic options. World J Gastroenterol, 2015, 21(43): 12211-12217.
12.	Brierley JD, Mary K, Gospodarowicz CW. UNION for inter-national cancer control (UICC). TNM classification of malignant tumours (Eighth Edition). John Wiley & Sons, Ltd. 2017: 85-86.
13.	Hundal R, Shaffer EA. Gallbladder cancer: epidemiology and outcome. Clin Epidemiol, 2014, 6: 99-109.
14.	Shindoh J, de Aretxabala X, Aloia TA, et al. Tumor location is a strong predictor of tumor progression and survival in T2 gallbladder cancer: an international multicenter study. Ann Surg, 2015, 261(4): 733-739.
15.	Lee H, Choi DW, Park JY, et al. Surgical strategy for T2 gallbladder cancer according to tumor location. Ann Surg Oncol, 2015, 22(8): 2779-2786.
16.	Park TJ, Ahn KS, Kim YH, et al. The optimal surgical resection approach for T2 gallbladder carcinoma: evaluating the role of surgical extent according to the tumor location. Ann Surg Treat Res, 2018, 94(3): 135-141.
17.	Isambert M, Leux C, Métairie S, et al. Incidentally discovered gallbladder cancer: When, why and which reoperation? J ViscSurg, 2011, 148(2): e77-e84.
18.	于勇, 姜小清. 膽囊癌的外科分期治療. 中華肝臟外科手術學電子雜志, 2012, 1(3): 151-156.
19.	邱應和, 劉辰, 易濱, 等. 181 例進展期膽囊癌外科治療的預后分析. 中華肝膽外科雜志, 2010, 16(9): 655-658.
20.	Lee SE, Kim SW, Han HS, et al. Surgical strategy for T2 gallbladder cancer: nationwide multicenter survey in Korea. J Korean Med Sci, 2018, 33(28): e186.
21.	Dasari BVM, Ionescu MI, Pawlik TM, et al. Outcomes of surgical resection of gallbladder cancer in patients presenting with jaundice: A systematic review and meta-analysis. J Surg Oncol, 2018, 118(3): 477-485.
22.	Feng FL, Liu C, Li B, et al. Role of radical resection in patients with gallbladder carcinoma and jaundice. Chin Med J, 2012, 125(5): 752-756.
23.	Ito M, Mishima Y, Sato T. An anatomical study of the lymphatic drainage of the gallbladder. Surg Radiol Anat, 1991, 13(2): 89-104.
24.	Miyazaki M, Ohtsuka M, Miyakawa S, et al. Classification of biliary tract cancers established by the Japanese Society of Hepato-Biliary-Pancreatic Surgery: 3^rd English edition. J Hepatobiliary Pancreat Sci, 2015, 22(3): 181-196.
25.	Creasy JM, Goldman DA, Dudeja V, et al. Systemic chemotherapy combined with resection for locally advanced gallbladder carcinoma: surgical and survival outcomes. J Am Coll Surg, 2017, 224(5): 906-916.
26.	Alzahrani NA, Valle SJ, Fisher OM, et al. Iterative cytoreductive surgery with or without hyperthermic intraperitoneal chemotherapy for colorectal peritoneal metastases: A multi-institutional experience. J Surg Oncol, 2019, 119(3): 336-346.
27.	Liu Y, Yonemura Y, Levine EA, et al. Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy for peritoneal metastases from a small bowel adenocarcinoma: multi-institutional experience. Ann Surg Oncol, 2018, 25(5): 1184-1192.
28.	Helm JH, Miura JT, Glenn JA, et al. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for malignant peritoneal mesothelioma: a systematic review and meta-analysis. Ann Surg Oncol, 2015, 22(5): 1686-1693.
29.	Ihemelandu C, Bijelic L, Sugarbaker PH. Iterative cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for recurrent or progressive diffuse malignant peritoneal mesothelioma: clinicopathologic characteristics and survival outcome. Ann Surg Oncol, 2015, 22(5): 1680-1685.
30.	Sommariva A, Tonello M, Cona C, et al. Iterative cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for recurrent peritoneal metastases. Anticancer Res, 2018, 38(9): 5521-5524.
31.	Randle RW, Levine EA, Clark CJ, et al. Cytoreductive surgery with hyperthermic intraperitoneal chemotherapy for gallbladder cancer: a retrospective review. Am Surg, 2014, 80(7): 710-713.
32.	Amblard I, Mercier F, Bartlett DL, et al. Cytoreductive surgery and HIPEC improve survival compared to palliative chemotherapy for biliary carcinoma with peritoneal metastasis: A multi-institutional cohort from PSOGI and BIG RENAPE groups. Eur J Surg Oncol, 2018, 44(9): 1378-1383.
33.	Abramson MA, Pandharipande P, Ruan D, et al. Radical resection for T1b gallbladder cancer: a decision analysis. HPB, 2009, 11: 656-663.
34.	Hari DM, Howard JH, Leung AM, et al. A 21-year analysis of stage I gallbladder carcinoma: is cholecystectomy alone adequate? HPB, 2013, 15: 40-48.
35.	姜小清, 邱應和. 意外膽囊癌的診斷與治療. 中華消化外科雜志, 2011, 10(2): 91-92.
36.	中國抗癌協會. 膽囊癌規范化診治專家共識(2016). 中華肝膽外科雜志, 2016, 22(11): 721-728.
37.	Benson AB 3rd, D'Angelica MI, Abrams TA, et al. NCCN clinical practice guidelines in oncology: Hepatobiliary cancers, version 2. J Natl Compr Canc Netw, 2014, 12(8): 1152-1182.
38.	Kim HS, Park JW, Kim H, et al. Optimal surgical treatment in patients with T1b gallbladder cancer: An international multicenter study. J Hepatobiliary Pancreat Sci, 2018, 25(12): 533-543.
39.	Vo E, Curley SA, Chai CY, et al. National failure of surgical staging for T1b gallbladder cancer. Ann Surg Oncol, 2019, 26(2): 604-610.
40.	?vajdler P, Daum O, Dubová M, et al. Frozen section examination of pancreas, gallbladder, extrahepatic biliary tree, liver, and gastrointestinal tract. Cesk Patol, 2018, 54(2): 63-71.

1. Edge SB, Byrd DR, Compton CC, et al. AJCC Cancer Staging Manual. 7th ed. New York: Springer, 2009: 211-217.
2. American Cancer Society. Cancer Facts and Figures 2013. Atlanta, GA: American Cancer Society, 2013.
3. Miquel JF, Covarrubias C, Villaroel L, et al. Genetic epidemiology of cholesterol cholelithiasis among Chilean Hispanics, Ame-rindians, and Maoris. Gastroenterology, 1998, 115(4): 937-946.
4. Sampliner RE, Bennett PH, Comess LJ, et al. Gallbladder disease in pima indians. Demonstration of high prevalence and early onset by cholecystography. N Engl J Med, 1970, 283(25): 1358-1364.
5. Zatonski WA, Lowenfels AB, Boyle P, et al. Epidemiologic aspects of gallbladder cancer: a case-control study of the SEARCH Program of the International Agency for Research on Cancer. J Natl Cancer Inst, 1997, 89(15): 1132-1138.
6. Everhart JE, Yeh F, Lee ET, et al. Prevalence of gallbladder disease in American Indian populations: findings from the Strong Heart Study. Hepatology, 2002, 35(6): 1507-1512.
7. Yamauchi S, Koga A, Matsumoto S, et al. Anomalous junction of pancreaticobiliary duct without congenital choledochal cyst: a possible risk factor for gallbladder cancer. Am J Gastroenterol, 1987, 82(1): 20-24.
8. Chijiiwa K, Kimura H, Tanaka M. Malignant potential of the gallbladder in patients with anomalous pancreaticobiliary ductal junction. The difference in risk between patients with and without choledochal cyst. Int Surg, 1995, 80(1): 61-64.
9. Bai Y, Liu ZS, Xiong JP, et al. Nomogram to predict overall survival after gallbladder cancer resection in China. World J Gastroenterol, 2018, 24(45): 5167-5178.
10. Kanthan R, Senger JL, Ahmed S, et al. Gallbladder Cancer in the 21^st Century. J Oncol, 2015, 2015: 967472.
11. Goetze TO. Gallbladder carcinoma: Prognostic factors and therapeutic options. World J Gastroenterol, 2015, 21(43): 12211-12217.
12. Brierley JD, Mary K, Gospodarowicz CW. UNION for inter-national cancer control (UICC). TNM classification of malignant tumours (Eighth Edition). John Wiley & Sons, Ltd. 2017: 85-86.
13. Hundal R, Shaffer EA. Gallbladder cancer: epidemiology and outcome. Clin Epidemiol, 2014, 6: 99-109.
14. Shindoh J, de Aretxabala X, Aloia TA, et al. Tumor location is a strong predictor of tumor progression and survival in T2 gallbladder cancer: an international multicenter study. Ann Surg, 2015, 261(4): 733-739.
15. Lee H, Choi DW, Park JY, et al. Surgical strategy for T2 gallbladder cancer according to tumor location. Ann Surg Oncol, 2015, 22(8): 2779-2786.
16. Park TJ, Ahn KS, Kim YH, et al. The optimal surgical resection approach for T2 gallbladder carcinoma: evaluating the role of surgical extent according to the tumor location. Ann Surg Treat Res, 2018, 94(3): 135-141.
17. Isambert M, Leux C, Métairie S, et al. Incidentally discovered gallbladder cancer: When, why and which reoperation? J ViscSurg, 2011, 148(2): e77-e84.
18. 于勇, 姜小清. 膽囊癌的外科分期治療. 中華肝臟外科手術學電子雜志, 2012, 1(3): 151-156.
19. 邱應和, 劉辰, 易濱, 等. 181 例進展期膽囊癌外科治療的預后分析. 中華肝膽外科雜志, 2010, 16(9): 655-658.
20. Lee SE, Kim SW, Han HS, et al. Surgical strategy for T2 gallbladder cancer: nationwide multicenter survey in Korea. J Korean Med Sci, 2018, 33(28): e186.
21. Dasari BVM, Ionescu MI, Pawlik TM, et al. Outcomes of surgical resection of gallbladder cancer in patients presenting with jaundice: A systematic review and meta-analysis. J Surg Oncol, 2018, 118(3): 477-485.
22. Feng FL, Liu C, Li B, et al. Role of radical resection in patients with gallbladder carcinoma and jaundice. Chin Med J, 2012, 125(5): 752-756.
23. Ito M, Mishima Y, Sato T. An anatomical study of the lymphatic drainage of the gallbladder. Surg Radiol Anat, 1991, 13(2): 89-104.
24. Miyazaki M, Ohtsuka M, Miyakawa S, et al. Classification of biliary tract cancers established by the Japanese Society of Hepato-Biliary-Pancreatic Surgery: 3^rd English edition. J Hepatobiliary Pancreat Sci, 2015, 22(3): 181-196.
25. Creasy JM, Goldman DA, Dudeja V, et al. Systemic chemotherapy combined with resection for locally advanced gallbladder carcinoma: surgical and survival outcomes. J Am Coll Surg, 2017, 224(5): 906-916.
26. Alzahrani NA, Valle SJ, Fisher OM, et al. Iterative cytoreductive surgery with or without hyperthermic intraperitoneal chemotherapy for colorectal peritoneal metastases: A multi-institutional experience. J Surg Oncol, 2019, 119(3): 336-346.
27. Liu Y, Yonemura Y, Levine EA, et al. Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy for peritoneal metastases from a small bowel adenocarcinoma: multi-institutional experience. Ann Surg Oncol, 2018, 25(5): 1184-1192.
28. Helm JH, Miura JT, Glenn JA, et al. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for malignant peritoneal mesothelioma: a systematic review and meta-analysis. Ann Surg Oncol, 2015, 22(5): 1686-1693.
29. Ihemelandu C, Bijelic L, Sugarbaker PH. Iterative cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for recurrent or progressive diffuse malignant peritoneal mesothelioma: clinicopathologic characteristics and survival outcome. Ann Surg Oncol, 2015, 22(5): 1680-1685.
30. Sommariva A, Tonello M, Cona C, et al. Iterative cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for recurrent peritoneal metastases. Anticancer Res, 2018, 38(9): 5521-5524.
31. Randle RW, Levine EA, Clark CJ, et al. Cytoreductive surgery with hyperthermic intraperitoneal chemotherapy for gallbladder cancer: a retrospective review. Am Surg, 2014, 80(7): 710-713.
32. Amblard I, Mercier F, Bartlett DL, et al. Cytoreductive surgery and HIPEC improve survival compared to palliative chemotherapy for biliary carcinoma with peritoneal metastasis: A multi-institutional cohort from PSOGI and BIG RENAPE groups. Eur J Surg Oncol, 2018, 44(9): 1378-1383.
33. Abramson MA, Pandharipande P, Ruan D, et al. Radical resection for T1b gallbladder cancer: a decision analysis. HPB, 2009, 11: 656-663.
34. Hari DM, Howard JH, Leung AM, et al. A 21-year analysis of stage I gallbladder carcinoma: is cholecystectomy alone adequate? HPB, 2013, 15: 40-48.
35. 姜小清, 邱應和. 意外膽囊癌的診斷與治療. 中華消化外科雜志, 2011, 10(2): 91-92.
36. 中國抗癌協會. 膽囊癌規范化診治專家共識(2016). 中華肝膽外科雜志, 2016, 22(11): 721-728.
37. Benson AB 3rd, D'Angelica MI, Abrams TA, et al. NCCN clinical practice guidelines in oncology: Hepatobiliary cancers, version 2. J Natl Compr Canc Netw, 2014, 12(8): 1152-1182.
38. Kim HS, Park JW, Kim H, et al. Optimal surgical treatment in patients with T1b gallbladder cancer: An international multicenter study. J Hepatobiliary Pancreat Sci, 2018, 25(12): 533-543.
39. Vo E, Curley SA, Chai CY, et al. National failure of surgical staging for T1b gallbladder cancer. Ann Surg Oncol, 2019, 26(2): 604-610.
40. ?vajdler P, Daum O, Dubová M, et al. Frozen section examination of pancreas, gallbladder, extrahepatic biliary tree, liver, and gastrointestinal tract. Cesk Patol, 2018, 54(2): 63-71.

CHINESE JOURNAL OF BASES AND CLINICS IN GENERAL SURGERY

膽囊癌的規范化手術治療

Abstract Full text Figures/Tables Video References Cited by

Previous Article

Next Article

Format

Content